Replies to post #134166 on Biotech Values

[DewDiligence]

I highly doubt this, at least in the near future. The FDA is by far the easiest agency to work with and the fastest for drug approvals. The EMEA is slower and the reimbursement situation in the EU makes getting profit slower. Other regions are even more difficult (e.g japan PMDA).

Thanks for chiming in. I’m inclined to agree with you and disagree with Steve Burrill.

[biomaven0]

The FDA is by far the easiest agency to work with and the fastest for drug approvals. The EMEA is slower

But the EMEA does sometimes seem to be "easier" - I can think of several drugs that got approved by the EMEA but not by the FDA (e.g. Pirfenidone, agomelatine).

Peter